New Implant Offers Hope for Treatment-Resistant Depression

A groundbreaking brain implant, approximately the size of a blueberry, is set to undergo human studies following FDA approval. Developed by Motif Neurotech, this device offers a novel therapeutic approach for individuals battling severe depression who have not found relief through conventional medications. The implant is designed to be placed just above the brain's protective membrane, targeting the central executive network, which is crucial for cognitive functions and is often underactive in patients with major depressive disorder.

Motif's technology aims to activate this network through patterned electrical stimulation, which can be administered wirelessly at home. This innovation builds upon decades of electrical stimulation therapies for depression, offering a less invasive alternative to existing experimental treatments. The procedure for implantation is an outpatient one, lasting about 20 minutes and not requiring traditional brain surgery. Powering the device involves wireless magnetoelectric technology, charged via a specialized cap worn by the patient during stimulation sessions.